Short answer
Prestige Consumer Healthcare Inc. (PBH) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $266M (up 6.5% year over year) with net income of $29M.
Q2 2026 key financials · XBRL
- Revenue
- $266M
- +6.5% YoY
- Net income
- $29M
- −38.5% YoY
- Operating margin
- 19.8%
- Gross margin
- 51.3%
- EPS (diluted)
- $0.61
- −35.8% YoY
Source: XBRL data from the Prestige Consumer Healthcare Inc. (PBH) Q2 2026 10-Q on SEC EDGAR. USD.
Prestige Consumer Healthcare Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $265.7M, up $16.2M or 6.5% YoY
- Gross margin 51.3% vs 56.2% YoY, pressured by Pillar5 optimization and inventory step-up amortization
- Best category Wellness, Sleep & Other revenue $14.3M, up 167.8% YoY across segments
- North American contribution margin 38.5% vs 43.0%; International contribution margin 36.7% vs 37.7%
- Cash $89.1M, up $25.3M; operating cash flow $70.8M vs $79.0M YoY
- Breathe Right acquisition drove $1,063.7M investing outflows and $1,018.5M financing inflows; supply shortages and inflation remained headwinds
Risk Factors
- Quarterly revenue volatility risk, with results potentially falling below analyst and investor expectations
- Market valuation risk, from weaker quarterly results adversely impacting outstanding securities
- No material new regulatory, legal, operational, competitive, or financial risks disclosed in provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Prestige Consumer Healthcare Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.